Ventilator-associated pneumonia (VAP) is linked to poor outcomes in patients with severe traumatic brain injury (TBI), yet its effect on cognitive disability is unknown. We hypothesized that there would be an association between severe cognitive disability and VAP in this patient population.
Methods:
We performed a post hoc analysis of a prospective, multi-center, observational study of adults with a severe, blunt TBI from 2020 to 2023. Patients were grouped by whether they developed VAP. Our primary outcome was severe cognitive disability, defined as a disability rating scale (DRS) score >13 at discharge (or 28 days post-injury if not discharged).
Results:
There were 309 patients in the cohort; 31.7% (n = 98) developed VAP. The VAP group had greater incidences of diffuse axonal injury (37.3% vs. 22.3%, p = 0.004), neurosurgical interventions (63.3 vs. 38.4%, p < 0.001), and tracheostomies (72.5% vs. 28.9%, p < 0.001). Patients with VAP had a longer duration of mechanical ventilation (13 d vs. 3 d, p < 0.001). Among patients with VAP, median time to diagnosis was 7 days (4–12), time to tracheostomy was 10 days (7–16), and time between the two events was 4 days (2–11). Greater proportions of cognitive disability (64.3% vs. 19.9%, p < 0.001) and worse median DRS scores (8 vs. 2, p < 0.001) occurred in the VAP group. On multi-variable regression analysis, VAP was an independent risk factor for severe cognitive disability (adjusted odds ratio [aOR]: 4.2, 95% CI: 2.2–7.8).
Conclusion:
Ventilator-associated pneumonia is common among patients with a severe TBI and is a risk factor for severe cognitive disability. Adherence to VAP prevention techniques may help mitigate cognitive impairment in this population.
Get full access to this article
View all access options for this article.
References
1.
ZygunDA, ZuegeDJ, BoiteauPJE, et al.Ventilator-associated pneumonia in severe traumatic brain injury. Neurocrit Care, 2006; 5(2):108–114; doi: 10.1385/NCC:5:2:108
2.
LiY, LiuC, XiaoW, et al.Incidence, risk factors, and outcomes of ventilator-associated pneumonia in traumatic brain injury: A meta-analysis. Neurocrit Care, 2020; 32(1):272–285; doi: 10.1007/s12028-019-00773-w
3.
EsnaultP, NguyenC, BordesJ, et al.Early-Onset ventilator-associated pneumonia in patients with severe traumatic brain injury: Incidence, risk factors, and consequences in cerebral oxygenation and outcome. Neurocrit Care, 2017; 27(2):187–198; doi: 10.1007/s12028-017-0397-4
4.
SkandsenT, FinnangerTG, AnderssonS, et al.Cognitive impairment 3 months after moderate and severe traumatic brain injury: A prospective follow-up study. Arch Phys Med Rehabil, 2010; 91(12):1904–1913; doi: 10.1016/j.apmr.2010.08.021
5.
OlverJH, PonsfordJL, CurranCA. Outcome following traumatic brain injury: A comparison between 2 and 5 years after injury. Brain Inj, 1996; 10(11):841–848; doi: 10.1080/026990596123945
6.
McCreaMA, GiacinoJT, BarberJ, et al.;TRACK-TBI Investigators. Functional outcomes over the first year after moderate to severe traumatic brain injury in the prospective, longitudinal TRACK-TBI study. JAMA Neurol, 2021; 78(8):982–992; doi: 10.1001/jamaneurol.2021.2043
7.
van DijckJTJM, DijkmanMD, OphuisRH, et al.In-hospital costs after severe traumatic brain injury: A systematic review and quality assessment. PLoS One, 2019; 14(5):e0216743; doi: 10.1371/journal.pone.0216743
8.
HumphreysI, WoodRL, PhillipsCJ, et al.The costs of traumatic brain injury: A literature review. Clinicoecon Outcomes Res, 2013; 5:281–287; doi: 10.2147/CEOR.S44625
9.
CernichAN, KurtzSM, MordecaiKL, et al.Cognitive Rehabilitation in Traumatic Brain Injury. Curr Treat Options Neurol, 2010; 12(5):412–423; doi: 10.1007/s11940-010-0085-6
10.
RobbaC, ReboraP, BanzatoE, et al.;Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Participants and Investigators. Incidence, risk factors, and effects on outcome of ventilator-associated pneumonia in patients with traumatic brain injury: Analysis of a large, multicenter, prospective, observational longitudinal study. Chest, 2020; 158(6):2292–2303; doi: 10.1016/j.chest.2020.06.064
11.
American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med, 2005; 171(4):388–416; doi: 10.1164/rccm.200405-644ST
12.
GiacinoJT, WhyteJ, BagiellaE, et al.Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med, 2012; 366(9):819–826; doi: 10.1056/NEJMoa1102609
13.
SalénBA, SpangfortEV, NygrenAL, et al.The disability rating index: An instrument for the assessment of disability in clinical settings. J Clin Epidemiol, 1994; 47(12):1423–1435; doi: 10.1016/0895-4356(94)90086-8
14.
TracyBM, CarlinMN, TysonJW, et al.The 11-Item Modified Frailty Index as a tool to predict unplanned events in traumatic brain injury. Am Surg, 2020; 86(11):1596–1601; doi: 10.1177/0003134820942196
15.
CordobésF, LobatoRD, RivasJJ, et al.Post-traumatic diffuse axonal brain injury. Analysis of 78 patients studied with computed tomography. Acta Neurochir (Wien), 1986; 81(1–2):27–35; doi: 10.1007/BF01456261
16.
TracyBM, SrinivasS, NahumKD, et al.The effect of amantadine on acute cognitive disability after severe traumatic brain injury: An institutional pilot study. Surgery, 2024; 175(3):907–912; doi: 10.1016/j.surg.2023.09.059
17.
JovanovicB, MilanZ, Markovic-DenicL, et al.Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in a Serbian trauma centre. Int J Infect Dis, 2015; 38:46–51; doi: 10.1016/j.ijid.2015.07.005
OddoM, NduomE, FrangosS, et al.Acute lung injury is an independent risk factor for brain hypoxia after severe traumatic brain injury. Neurosurgery, 2010; 67(2):338–344; doi: 10.1227/01.NEU.0000371979.48809.D9
20.
ChangJJJ, YounTS, BensonD, et al.Physiologic and functional outcome correlates of brain tissue hypoxia in traumatic brain injury. *Crit Care Med, 2009; 37(1):283–290; doi: 10.1097/CCM.0b013e318192fbd7
21.
YanEB, SatgunaseelanL, PaulE, et al.Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury. J Neurotrauma, 2014; 31(7):618–629; doi: 10.1089/neu.2013.3087
22.
HuPJ, PittetJF, KerbyJD, et al.Acute brain trauma, lung injury, and pneumonia: More than just altered mental status and decreased airway protection. Am J Physiol Lung Cell Mol Physiol, 2017; 313(1):L1–L15; doi: 10.1152/ajplung.00485.2016
23.
LustenbergerT, KernM, ReljaB, et al.The effect of brain injury on the inflammatory response following severe trauma. Immunobiology, 2016; 221(3):427–431; doi: 10.1016/j.imbio.2015.11.011
24.
ChenouardA, ChesneauM, BrazaF, et al.Phenotype and functions of B cells in patients with acute brain injuries. Mol Immunol, 2015; 68(2 Pt A):350–356; doi: 10.1016/j.molimm.2015.09.001
25.
VenturiL, MirandaM, SelmiV, et al.Systemic sepsis exacerbates mild post-traumatic brain injury in the rat. J Neurotrauma, 2009; 26(9):1547–1556; doi: 10.1089/neu.2008.0723
26.
SkandsenT, KvistadKA, SolheimO, et al.Prevalence and impact of diffuse axonal injury in patients with moderate and severe head injury: A cohort study of early magnetic resonance imaging findings and 1-year outcome: Clinical article. J Neurosurg, 2010; 113(3):556–563; doi: 10.3171/2009.9.JNS09626
27.
Vieira R deCA, PaivaWS, de OliveiraDV, et al.Diffuse axonal injury: Epidemiology, outcome and associated risk factors. Front Neurol, 2016; 7:178; doi: 10.3389/fneur.2016.00178
28.
EliI, JoyceE, HawrylukGWJ. Use of guidelines in the management of traumatic brain injury. In: Controversies in Severe Traumatic Brain Injury Management. (TimmonsSD., ed.) Springer International Publishing; 2018:207–230. doi:10.1007/978-3-319-89477-5_17
29.
RobbaC, GalimbertiS, GrazianoF, et al.;CENTER-TBI ICU Participants and Investigators. Tracheostomy practice and timing in traumatic brain-injured patients: A CENTER-TBI study. Intensive Care Med, 2020; 46(5):983–994; doi: 10.1007/s00134-020-05935-5
30.
Di BattistaAP, RhindSG, HutchisonMG, et al.Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J Neuroinflammation, 2016; 13(1):40; doi: 10.1186/s12974-016-0500-3
31.
CottonBA, SnodgrassKB, FlemingSB, et al.Beta-Blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma, 2007; 62(1):26; doi: 10.1097/TA.0b013e31802d02d0
32.
HabibT, SabryA, El-BeheiryA, et al.Role of early propranolol in weaning from mechanical ventilator in severe traumatic brain injury patients. Res Opin Anesth Intensive Care, 2018; 5(1):15; doi: 10.4103/roaic.roaic_58_17
33.
Handbook of Clinical Neurology 3rd Series. In: Handbook of Clinical Neurology. Vol 127. Elsevier; 2015:v–vi; doi:10.1016/B978-0-444-52892-6.09994-3
TurgeonAF, LauzierF, SimardJF, et al.;Canadian Critical Care Trials Group. Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: A Canadian multicentre cohort study. CMAJ, 2011; 183(14):1581–1588; doi: 10.1503/cmaj.101786
36.
JochemsD, van WessemKJP, HouwertRM, et al.Outcome in Patients with Isolated Moderate to Severe Traumatic Brain Injury. Crit Care Res Pract, 2018; 2018:e3769418; doi: 10.1155/2018/3769418
37.
HeimesJ, BraxtonC, NazirN, et al.Implementation and enforcement of ventilator-associated pneumonia prevention strategies in trauma patients. Surg Infect (Larchmt), 2011; 12(2):99–103; doi: 10.1089/sur.2009.028
38.
Dahyot-FizelierC, LasockiS, KerforneT, et al.;PROPHY—VAP Study Group and the ATLANREA Study Group. Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: A multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial. Lancet Respir Med, 2024; 12(5):375–385; doi: 10.1016/S2213-2600(23)00471-X
39.
KlompasM. Antibiotic prophylaxis for patients with acute brain injury. Lancet Respir Med, 2024; 12(5):340–341; doi: 10.1016/S2213-2600(24)00006-7
40.
ArmstrongFD, DrotarD. Multi-Institutional and multidisciplinary research collaboration. In: Handbook of Research in Pediatric and Clinical Child Psychology: Practical Strategies and Methods. (DrotarD. ed.) Springer US; 2000:281–303; doi:10.1007/978-1-4615-4165-3_13
